Seth Klarman started to build up the position in Enzon Pharmaceuticals in Q3 2009 and continued to invest until Q3 2010. Since then they sold 10.4 Million shares. The investor completely sold their stake between Q4 2010 and Q1 2014.
Avg closing price
Price range
Sold -4.34 Million shares
Q1 2014
Avg closing price
-
Price range
-
-
-
Sold 43.6% shares (-3.35 Million shares)
Q4 2013
Avg closing price
-
Price range
-
-
-
Sold 2.0% shares (-159 Thousand shares)
Q1 2013
Avg closing price
-
Price range
-
-
-
Sold 12.8% shares (-1.15 Million shares)
Q4 2012
Avg closing price
-
Price range
-
-
-
Sold 0.7% shares (-64.3 Thousand shares)
Q1 2011
Avg closing price
-
Price range
-
-
-
Sold 12.7% shares (-1.32 Million shares)
Q4 2010
Avg closing price
-
Price range
-
-
-
Increased shares by 2.0% (+207 Thousand shares)
Q3 2010
Avg closing price
-
Price range
-
-
-
Increased shares by 10.6% (+973 Thousand shares)
Q2 2010
Avg closing price
-
Price range
-
-
-
Increased shares by 13.9% (+1.12 Million shares)
Q1 2010
Avg closing price
-
Price range
-
-
-
Increased shares by 290.2% (+6.01 Million shares)
Q4 2009